Indian Pharmaceutical Companies: Innovative HIV Drug Reformulations (RedNova)
The FDA has tentatively approved new HIV drug co-formulations combining lamivudine, zidovudine (both originally developed by GSK) and nevirapine (by Boehringer Ingelheim) for use under the PEPFAR program.

Revolutions Medical Corporation Has Chosen Strategic Product Development, Inc. For Their FDA Application Process (RedNova)
MOUNT PLEASANT, S.C., Feb. 6 /PRNewswire/ -- Revolutions Medical Corporation, Mount Pleasant, SC is pleased to announce an agreement with Strategic Product Development, Inc. which will provide FDA regulatory compliance, manufacturing management capabilities and ongoing product development.

Genta Announces The Company Will Appeal FDA Action On New Drug Application Of Genasense(R) In Chronic Lymphocytic ... (Medical News Today)
Genta Incorporated (Nasdaq: GNTA) today announced that the Company will appeal the non-approvable notice from the Food and Drug Administration's (FDA) Office of Oncology Drug Products of its New Drug Application (NDA) for the use of Genasense(R) (oblimersen sodium) Injection plus chemotherapy in patients with chronic lymphocytic leukemia (CLL). [click link for full article]